CSL Limited announces tender offer to acquire Vifor Pharma Ltd Agreement announced on the Australian Securities Exchange and SIX Swiss Exchange on 14 December 2021Cash offer at US$179.25 per shareo Offer equivalent to CHF167 per share1o Proposed ordinary dividend expected to.
Global biotechnology leader CSL Limited (ASX: CSL; USOTC:CSLLY) and Vifor Pharma Ltd (SIX:VIFN; ISIN:CH0364749348), a global specialty pharmaceutical company with leadership in Iron Deficiency, Nephrology & Cardio-Renal Therapies, today announced that they have entered into a definitive agreement for CSL to launch .
/PRNewswire/ CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd - Agreement Announced on the Australian Stock Exchange and SIX Swiss Exchange 14.
Agreement Announced on the Australian Stock Exchange and SIX Swiss Exchange 14 December, 2021 Expands CSL’s leadership across an attractive portfolio